| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Feb 28, 2026 | Option exercise(M) | 261K | $0.15 | $39K | 1.7M |
| Jan 24, 2026 | Option exercise(M) | 15K | — | — | 1.4M |
| Sep 19, 2025 | Grant(A) | 1.0M | — | $0 | 1.4M |
| Aug 14, 2025 | Option exercise(M) | 197K | $0.00 | $20 | 397K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Feb 28, 2026 | Option exercise(M) | 261K | — | $0 | 3.3M |
| Jan 24, 2026 | Option exercise(M) | 15K | — | $0 | 15K |
| Sep 19, 2025 | Grant(A) | 3.6M | — | $0 | 3.6M |
| Aug 14, 2025 | Option exercise(M) | 60K | — | $0 | 0 |
| Aug 14, 2025 | Option exercise(M) | 69K | — | $0 | 0 |
| Aug 14, 2025 | Option exercise(M) | 25K | — | $0 | 0 |
| Aug 14, 2025 | Option exercise(M) | 43K | — | $0 | 0 |
| Oct 16, 2024 | Disposed to issuer(D) | 69K | — | — | 0 |
| Oct 16, 2024 | Grant(A) | 69K | — | — | 69K |
| Oct 16, 2024 | Disposed to issuer(D) | 43K | — | — | 0 |
| Oct 16, 2024 | Grant(A) | 43K | — | — | 43K |
| Oct 16, 2024 | Disposed to issuer(D) | 36K | — | — | 0 |
| Oct 16, 2024 | Grant(A) | 36K | — | — | 36K |
| Oct 16, 2024 | Disposed to issuer(D) | 25K | — | — | 0 |
| Oct 16, 2024 | Grant(A) | 25K | — | — | 25K |
| Feb 6, 2022 | Grant(A) | 43K | — | $0 | 43K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-214890) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Eloxx Pharmaceuticals, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.